Gynae BT_Lucknow_2018

TMH EMBRACE Data Prospective MR Based Brachytherapy (N = 94 patients) Dec 2009 – March 2014

Total no of patients

47/100 patients

Median Age (range)

49(42 - 65) years

Histology

Squamous Carcinoma

81

Adenocarcinoma

09

AdenoSquamous

04

FIGO Stage (n)

94

IIB

31

IIIB

55

IVA ( Bladder mucosa invasion)

08

Intracavitary Brachytherapy (HDR)

4 fractions of 7 Gy to HRCTV

Median follow-Up (IQR)

39 (26-50) months